Evidence map›Paper›PMID 35771295›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2022

Huntington's disease and neurovascular structure of retina.

Elahe Amini, Mehdi Moghaddasi, Seyed Amir Hassan Habibi, Zahra Azad, Shahnaz Miri, Naveed Nilforushan, Reza Mirshahi, Esther Cubo, Nahid Mohammadzadeh, Mohammad Rohani

Abstract read
PubMed Publisher
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 3 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 3 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Vascular regeneration and blood flow recovery in glaucoma.Frontiers in cell and developmental biology · 2026
    Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Elahe AminiSkull Base Research Center, The Five Senses Health Institute, Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.ORCID http://orcid.org/0000-0002-7223-2391
Mehdi MoghaddasiSkull Base Research Center, The Five Senses Health Institute, Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.ORCID http://orcid.org/0000-0002-3164-180X
Seyed Amir Hassan HabibiDepartment of Neurology, Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.ORCID http://orcid.org/0000-0001-6896-4779
Zahra AzadSkull Base Research Center, The Five Senses Health Institute, Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.ORCID http://orcid.org/0000-0002-2643-0354
Shahnaz MiriNeuro-Ophthalmology Division, Wilmer Eye Institute, Johns Hopkins Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-9386-9538
Naveed NilforushanEye Research Center, The Five Senses Health Institute, Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.ORCID http://orcid.org/0000-0001-7720-1757
Reza MirshahiEye Research Center, The Five Senses Health Institute, Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.ORCID http://orcid.org/0000-0002-5997-6417
Esther CuboNeurology Department Hospital Universitario Burgos, University of Burgos, Burgos, Spain.
Nahid MohammadzadehDepartment of Neurology, Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.ORCID http://orcid.org/0000-0001-5609-7938
Mohammad RohaniSkull Base Research Center, The Five Senses Health Institute, Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran. mohammadroohani@gmail.com.ORCID http://orcid.org/0000-0002-5409-1804
Iran University of Medical Sciences · IRHospital Universitario de Burgos · ESJohns Hopkins University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRetinal biomarkers in neurodegenerative disorders have attracted much attention in recent years. Recent studies have reported visual dysfunction in Huntington's disease (HD). However, little is known about retinal structural changes in HD.

methodsA total of 50 subjects, including 25 motor-manifest HD patients and 25 gender- and age-matched controls, were enrolled. Unified Huntington's Disease Rating Score-Motor part was assessed in HD patients. Spectral-domain Optical Coherence Tomography (SD-OCT) was used to evaluate the macular thickness and peripapillary retinal nerve fiber layer (pRNFL). Superficial and deep capillary plexus densities were measured using OCT angiography (OCTA). To account for inter-eye correlation, generalized estimating equation (GEE) model was used.

resultsHD patients had a significant reduction in macular thickness in both inner and outer superior sectors and the inferior outer sector. Inferior pRNFLs were significantly decreased in thickness. There was no significant difference in retinal capillary plexus density between the two groups. Age and disease duration were negatively correlated with macular thickness in HD patients. However, the severity of motor involvement was not correlated with SD-OCT or OCTA parameters.

conclusionsWe observed attenuated pRNFL and macular retinal thickness in patients with HD, independent of macular capillary plexus parameters. It can support the hypothesis that the retina may be a potential biomarker for monitoring the neurodegenerative process in HD.

Indexed as

Huntington DiseaseNerve FibersBiomarkersHumansRetinaTomography, Optical CoherenceBiomarkersHuntington diseaseNeurodegenerative diseasesOptical coherenceRetinaTomography

Identifiers

PMID35771295
OpenAlexW4283721432

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.